Urine 4-(methylnitrosamino)-1-(3) pyridyl-1-butanol and cotinine in Alaska native postpartum women and neonates comparing smokers and smokeless tobacco users

References

• HHS. How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general. Atlanta, GA: U.S: Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2010.
   Google Scholar
• Dechanet C, Anahory T, Mathieu Daude JC, et al. Effects of cigarette smoking on reproduction. Hum Reprod Update. 2011 Jan-Feb;17(1):76–6. PMID: 20685716; eng.
   PubMed Web of Science ®Google Scholar
• Hecht SS. Research opportunities related to establishing standards for tobacco products under the family smoking prevention and tobacco control act. Nicotine Tob Res. 2012 Jan;14(1):18–28. . PMID: 21324834PMCID: PMC3242967. eng.
   PubMed Web of Science ®Google Scholar
• Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 2003 Oct;3(10):733–744. PMID: 14570033; eng.
   PubMed Web of Science ®Google Scholar
• Avila-Tang E, Al-Delaimy WK, Ashley DL, et al. Assessing secondhand smoke using biological markers. Tob Control. 2013 May;22(3):164–171. PMID: 22940677; PMCID: PMC3639350. eng.
   PubMed Web of Science ®Google Scholar
• Tong VT, Dietz PM, Morrow B, et al. Trends in smoking before, during, and after pregnancy–pregnancy risk assessment monitoring system, USA, 40 sites, 2000–2010. Morb Mortal Wkly RepSurveillance Summar(Washington, DC: 2002). 2013 Nov 8;62(6):1–19. PMID: 24196750; eng.
   PubMed Web of Science ®Google Scholar
• Kim SY, England L, Dietz PM, et al. Patterns of cigarette and smokeless tobacco use before, during, and after pregnancy among Alaska native and white women in Alaska, 2000–2003. Matern Child Health J. 2010 May;14(3):365–372. PMID: 19139981; eng.
   Web of Science ®Google Scholar
• Renner CC, Enoch C, Patten CA, et al. Iqmik: a form of smokeless tobacco used among Alaska natives. Am J Health Behav. 2005 Nov-Dec;29(6):588–594. PMID: 16336113; eng.
   PubMed Web of Science ®Google Scholar
• Renner CC, Patten CA, Enoch C, et al. Focus groups of Y-K Delta Alaska natives: attitudes toward tobacco use and tobacco dependence interventions. Prev Med. 2004 Apr;38(4):421–431. PMID: 15020175.
   PubMed Web of Science ®Google Scholar
• Dempsey DA, Hajnal BL, Partridge JC, et al. Tone abnormalities are associated with maternal cigarette smoking during pregnancy in in utero cocaine-exposed infants. Pediatrics. 2000 Jul;106(1 Pt 1):79–85. PMID: 10878153
   Web of Science ®Google Scholar
• Florek E, Piekoszewski W, Basior A, et al. Effect of maternal tobacco smoking or exposure to second-hand smoke on the levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine of mother and the first urine of newborn. J Physiol Pharmacology: Off J Polish Physiol Soc. 2011 Jun;62(3):377–383. PMID: 21893699; eng
   Web of Science ®Google Scholar
• Kirchheiner J, Klein C, Meineke I, et al. Bupropion and 4-OH-bupropion pharmacokinetics in relation to genetic polymorphisms in CYP2B6. Pharmacogenetics. 2003 Oct;13(10):619–626. PMID: 14515060; eng.
   PubMedGoogle Scholar
• Lackmann GM, Salzberger U, Tollner U, et al. Metabolites of a tobacco-specific carcinogen in urine from newborns. J Natl Cancer Inst. 1999 Mar 3;91(5):459–465. PMID: 10070946; eng.
   Google Scholar
• Milunsky A, Carmella SG, Ye M, et al. A tobacco-specific carcinogen in the fetus. Prenat Diagn. 2000 Apr;20(4):307–310. PMID: 10740203; eng
   Web of Science ®Google Scholar
• Flanagan CA, Koller KR, Wolfe AW, et al. Fetal exposure to carcinogens with tobacco use in pregnancy: phase 1 MAW study findings. Nicotine Tob Res. 2016 Nov;18(11):2162–2168. PMID: 27190400; PMCID: PMC5055741.
   Web of Science ®Google Scholar
• Koller KR, Flanagan CA, Day GE, et al. Developing a biomarker feedback intervention to motivate smoking cessation during pregnancy: phase II MAW study. Nicotine Tob Res. 2017 Aug 1;19(8):930–936. PMID: 28003506.
   PubMed Web of Science ®Google Scholar
• Jacob P 3rd, Wilson M, Benowitz NL. Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J Chromatogr. 1981 Jan 02;222(1):61–70. PMID: 6783675
   Web of Science ®Google Scholar
• Jacob P 3rd, Yu L, Duan M, et al. Determination of the nicotine metabolites cotinine and trans-3ʹ-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity. J Chromatogr B, Anal Technologies Biomed Life Sci. 2011 Feb 01;879(3–4):267–276. PMID: 21208832; PMCID: PMC3050598. eng.
   PubMed Web of Science ®Google Scholar
• Jacob P 3rd, Havel C, Lee DH, et al. Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry. Anal Chem. 2008 Nov 01;80(21):8115–8121. PMID: 18841944; PMCID: PMC3167662.
   Web of Science ®Google Scholar
• Kastl JT. Renal function in the fetus and neonate - the creatinine enigma. Semin Fetal Neonatal Med. 2017 Apr;22(2):83–89. . PMID: 28109705; eng.
   Web of Science ®Google Scholar
• Benowitz NL, Renner CC, Lanier AP, et al. Exposure to nicotine and carcinogens among Southwestern Alaskan Native cigarette smokers and smokeless tobacco users. Cancer epidemiology, biomarkers & prevention: a publication of the American association for cancer research. Cosponsored by Am Soc Prev Oncol. 2012 Jun;21(6):934–942. PMID: 22490317; PMCID: PMC3444141. eng.
   Google Scholar
• Stanfill SB, Connolly GN, Zhang L, et al. Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines. Tob Control. 2011 May;20(3):e2. PMID: 21109685; eng.
   Web of Science ®Google Scholar
• Correa E, Joshi PA, Castonguay A, et al. The tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is an active transplacental carcinogen in Syrian golden hamsters. Cancer Res. 1990 Jun 01;50(11):3435–3438. PMID: 2334940; eng
   PubMed Web of Science ®Google Scholar
• Schuller HM, Jorquera R, Lu X, et al. Transplacental carcinogenicity of low doses of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone administered subcutaneously or intratracheally to hamsters. J Cancer Res Clin Oncol. 1994;120(4):200–203. PMID: 8288673; eng.
   Web of Science ®Google Scholar
• John EM, Savitz DA, Sandler DP. Prenatal exposure to parents’ smoking and childhood cancer. Am J Epidemiol. 1991 Jan 15;;133(2):123–132. PMID: 1822074; eng
   PubMed Web of Science ®Google Scholar
• Sasco AJ, Vainio H. From in utero and childhood exposure to parental smoking to childhood cancer: a possible link and the need for action. Hum Exp Toxicol. 1999 Apr;18(4):192–201. . PMID: 10333301; eng.
   PubMed Web of Science ®Google Scholar